Aventis Pharma Obtains Additional Approval for Taxoid Antitumor Agent TAXOTERE Injection

October 19, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Tokyo (JCN) - Aventis Pharma of the sanofi-aventis Group announced on August 19 that it has obtained additional approval for TAXOTERE Injection, its proprietary taxoid antitumor agent, from the Ministry of Health, Labor and Welfare as of August 18.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals

Sanofi Sanofi